Sanyou Biopharmaceuticals News and Resources

Sanyou Biopharmaceuticals has introduced a comprehensive product line aimed at advancing monkeypox research and treatment development. The product range, consisting of 65 items, includes natural epitope antigens, high-affinity monoclonal antibodies, and overexpression cell lines, all designed to target key sites

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. has officially introduced its “oneClick+” platform, designed to enhance antibody development efficiency. This new platform integrates 90% of the mainstream antibody structures currently available, facilitating the design of various antibody configurations. Launched recently, the “oneClick+”